← Back to Clinical Trials
Recruiting NCT07718464

NCT07718464 FST Analysis Supporting Timely Therapy and Risk Assessment Via Clinical Decision Support for Kids

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07718464
Status Recruiting
Phase —
Sponsor Children's Hospital Medical Center, Cincinnati
Condition Acute Kidney Injury
Study Type OBSERVATIONAL
Enrollment 120 participants
Start Date 2026-05-27
Primary Completion 2028-05

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Furosemide Stress Test Clinical Decision Support Tool

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 120 participants in total. It began in 2026-05-27 with a primary completion date of 2028-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to learn whether adding a clinical decision support tool to the electronic medical record helps clinicians use the furosemide stress test in critically ill children at high risk for severe acute kidney injury (AKI). The main question it aims to answer is: Does implementing the decision support tool reduce fluid overload and help predict which children will receive dialysis? Researchers will identify children admitted to the pediatric intensive care unit who are at high risk for AKI using risk stratification and biomarker testing, then compare outcomes in the two years after the tool is introduced with the two years before.

Eligibility Criteria

Inclusion Criteria: * Admitted to the pediatric intensive care unit (PICU) * Renal Angina Index (RAI) greater than or equal to 8 (RAI+) * Urine NGAL greater than or equal to 150 ng/mL (NGAL+) Exclusion Criteria: * Receipt of renal replacement therapy prior to PICU admission

Frequently Asked Questions

Who can join the NCT07718464 clinical trial?

This trial is open to participants of all sexes, studying Acute Kidney Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07718464 currently recruiting?

Yes, NCT07718464 is actively recruiting participants. Visit ClinicalTrials.gov or contact Children's Hospital Medical Center, Cincinnati to inquire about joining.

Where is the NCT07718464 trial being conducted?

This trial is being conducted at Cincinnati, United States.

Who is sponsoring the NCT07718464 clinical trial?

NCT07718464 is sponsored by Children's Hospital Medical Center, Cincinnati. The trial plans to enroll 120 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology